Clinical Trial Update: Short-term Effect of Intravitreal Dexamethasone Implant in Refractory Diabetic Macular Edema [Phase 4]

View source ↗

Summary

Phase 4 clinical trial reporting short-term outcomes of the dexamethasone intravitreal implant in patients with refractory diabetic macular edema; the study has…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Ozurdex (dexamethasone intravitreal implant) (dexamethasone)

Snippet

Sponsor: Asociación para Evitar la Ceguera en México | Conditions: Diabetic Macular Edema | Phase 4 | Status: COMPLETED